{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:51:42Z","timestamp":1789177902194,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012397","name":"Army Medical University","doi-asserted-by":"publisher","award":["2017MPRC-15"],"award-info":[{"award-number":["2017MPRC-15"]}],"id":[{"id":"10.13039\/501100012397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.intimp.2019.106078","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T13:24:00Z","timestamp":1575897840000},"page":"106078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Therapeutic drug monitoring and safety of voriconazole in elderly patients"],"prefix":"10.1016","volume":"78","author":[{"given":"Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cger.2007.01.010","article-title":"Infections in the elderly","volume":"23","author":"Liang","year":"2007","journal-title":"Clin. Geriatr. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.emc.2016.04.005","article-title":"Sepsis and other infectious disease emergencies in the elderly","volume":"34","author":"Liang","year":"2016","journal-title":"Emerg. Med. Clin. North Am."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.09.011","article-title":"Voriconazole hepatotoxicity in severe liver dysfunction","volume":"66","author":"Solis-Munoz","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2019.106078_b0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/IDR.S179078","article-title":"The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro","volume":"11","author":"Xu","year":"2018","journal-title":"Infect. Drug Resis."},{"issue":"7","key":"10.1016\/j.intimp.2019.106078_b0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/bcp.13595","article-title":"Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients","volume":"84","author":"Lin","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2019.106078_b0035","first-page":"e01211","article-title":"Observational study of associations between voriconazole therapeutic drug monitoring, toxicity, and outcome in liver transplant patients","volume":"61","author":"Hashemizadeh","year":"2017","journal-title":"Antimicrob. Age. Chemother."},{"issue":"10","key":"10.1016\/j.intimp.2019.106078_b0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Bruggemann","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/fcp.12422","article-title":"Inflammation is a potential risk factor of voriconazole overdose in hematological patients","volume":"33","author":"Gautier-Veyret","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106078_b0050","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/bcp.13627","article-title":"Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole","volume":"84","author":"Vreugdenhil","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/dkw349","article-title":"Voriconazole metabolism is influenced by severe inflammation: a prospective study","volume":"72","author":"Veringa","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.intimp.2019.106078_b0060","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.02830-15","article-title":"Longitudinal analysis of the effect of inflammation on voriconazole trough concentrations","volume":"60","author":"Encalada Ventura","year":"2016","journal-title":"Antimicrob. Age. Chemother."},{"issue":"5","key":"10.1016\/j.intimp.2019.106078_b0065","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740330903485637","article-title":"Voriconazole therapeutic drug monitoring: focus on safety","volume":"9","author":"Pasqualotto","year":"2010","journal-title":"Exp. Opin. Drug. Saf."},{"issue":"12","key":"10.1016\/j.intimp.2019.106078_b0075","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/AAC.03820-14","article-title":"Inflammation is associated with voriconazole trough concentrations","volume":"58","author":"van Wanrooy","year":"2014","journal-title":"Antimicrob. Age. Chemother."},{"issue":"8","key":"10.1016\/j.intimp.2019.106078_b0080","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1532-5415.2005.53421.x","article-title":"Procalcitonin and infection in elderly patients","volume":"53","author":"Stucker","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.intimp.2019.106078_b0085","first-page":"4312737","article-title":"Procalcitonin is a prognostic marker of hospital outcomes in patients with critical limb ischemia and diabetic foot infection","volume":"2019","author":"Meloni","year":"2019","journal-title":"J. Diab. Res."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0090","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations","volume":"36","author":"Becker","year":"2008","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.intimp.2019.106078_b0095","doi-asserted-by":"crossref","first-page":"e0206527","DOI":"10.1371\/journal.pone.0206527","article-title":"The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics","volume":"13","author":"Yunus","year":"2018","journal-title":"PLoS ONE"},{"issue":"8\u20139","key":"10.1016\/j.intimp.2019.106078_b0100","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: Implications for disease ?","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.1840090222","article-title":"The effect of age upon liver volume and apparent liver blood flow in healthy man","volume":"9","author":"Wynne","year":"1989","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.intimp.2019.106078_b0110","doi-asserted-by":"crossref","first-page":"e14254","DOI":"10.1371\/journal.pone.0014254","article-title":"Alanine aminotransferase decreases with age: the Rancho Bernardo Study","volume":"5","author":"Dong","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","article-title":"Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions","volume":"61","author":"Sotaniemi","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0120","doi-asserted-by":"crossref","first-page":"020406","DOI":"10.7189\/jogh.09.020406","article-title":"Time trends in facility-based and private-sector childbirth care: analysis of Demographic and Health Surveys from 25 sub-Saharan African countries from 2000 to 2016","volume":"9","author":"Doctor","year":"2019","journal-title":"J Glob Health"},{"issue":"12","key":"10.1016\/j.intimp.2019.106078_b0125","doi-asserted-by":"crossref","first-page":"e0207646","DOI":"10.1371\/journal.pone.0207646","article-title":"Factors associated with healthcare utilization among community-dwelling elderly in Shanghai, China","volume":"13","author":"Jiang","year":"2018","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.intimp.2019.106078_b0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/605562","article-title":"Infectious disease hospitalizations in the United States","volume":"49","author":"Christensen","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"21","key":"10.1016\/j.intimp.2019.106078_b0135","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/archinte.165.21.2514","article-title":"Infectious disease hospitalizations among older adults in the United States from 1990 through 2002","volume":"165","author":"Curns","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.intimp.2019.106078_b0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcrc.2013.03.018","article-title":"Impact of older age and nursing home residence on clinical outcomes of US emergency department visits for severe sepsis","volume":"28","author":"Ginde","year":"2013","journal-title":"J. Crit. Care"},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","article-title":"The effect of age on the development and outcome of adult sepsis","volume":"34","author":"Martin","year":"2006","journal-title":"Crit. Care Med."},{"issue":"24","key":"10.1016\/j.intimp.2019.106078_b0150","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2010.851","article-title":"Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis","volume":"303","author":"Mayr","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2710.2009.01070.x","article-title":"Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient","volume":"35","author":"Capone","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"46","key":"10.1016\/j.intimp.2019.106078_b0160","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.3748\/wjg.v19.i46.8459","article-title":"Liver physiology and liver diseases in the elderly","volume":"19","author":"Tajiri","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.intimp.2019.106078_b0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/13693780500129814","article-title":"Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus","volume":"43","author":"Rodrigues","year":"2005","journal-title":"Med. Mycol."},{"issue":"8","key":"10.1016\/j.intimp.2019.106078_b0170","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/jps.24064","article-title":"Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis","volume":"103","author":"Vanstraelen","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM198307213090305","article-title":"The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia","volume":"309","author":"Weiss","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2019.106078_b0180","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1248\/bpb.b14-00768","article-title":"Population pharmacokinetics in china: the dynamics of intravenous voriconazole in critically ill patients with pulmonary disease","volume":"38","author":"Chen","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.intimp.2019.106078_b0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/jcpt.12817","article-title":"Impact of voriconazole plasma concentrations on treatment response in critically ill patients","volume":"44","author":"Ruiz","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metabol. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.intimp.2019.106078_b0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106078_b0200","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metabol. Dispos. Biol. Fate Chem."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metabol. Dispos. Biol. Fate Chem."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1476-5381.2009.00433.x","article-title":"Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target","volume":"159","author":"Becker","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2019.106078_b0215","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1177\/0300060518766640","article-title":"Procalcitonin and albumin as prognostic biomarkers in elderly patients with a risk of bacterial infection","volume":"46","author":"Higashikawa","year":"2018","journal-title":"J. Int. Med. Res."},{"issue":"5","key":"10.1016\/j.intimp.2019.106078_b0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.annemergmed.2012.05.027","article-title":"Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis","volume":"60","author":"Yo","year":"2012","journal-title":"Ann. Emerg. Med."},{"issue":"2","key":"10.1016\/j.intimp.2019.106078_b0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2019.106078_b0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamapediatrics.2015.3210","article-title":"Use of procalcitonin assays to predict serious bacterial infection in young febrile infants","volume":"170","author":"Milcent","year":"2016","journal-title":"JAMA Pediatr."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0235","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.archger.2014.07.011","article-title":"Determinants of mortality among older adults with pressure ulcers","volume":"59","author":"Khor","year":"2014","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"7","key":"10.1016\/j.intimp.2019.106078_b0240","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4065\/82.7.817","article-title":"Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota","volume":"82","author":"McNamara","year":"2007","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.intimp.2019.106078_b0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajic.2007.06.008","article-title":"Prevalence of nursing home-associated infections in the Department of Veterans Affairs nursing home care units","volume":"36","author":"Tsan","year":"2008","journal-title":"Am. J. Infect. Control"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919323239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919323239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:16:26Z","timestamp":1761585386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919323239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"alternative-id":["S1567576919323239"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106078","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring and safety of voriconazole in elderly patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106078"}}